Compare ORMP & NMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ORMP | NMT |
|---|---|---|
| Founded | 2002 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 134.1M | 107.8M |
| IPO Year | 2010 | N/A |
| Metric | ORMP | NMT |
|---|---|---|
| Price | $3.58 | $12.10 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 163.8K | 14.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 6.92% | 3.21% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.26 | N/A |
| Revenue | ★ $1,340,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $2.86 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.82 | $10.90 |
| 52 Week High | $3.76 | $12.33 |
| Indicator | ORMP | NMT |
|---|---|---|
| Relative Strength Index (RSI) | 58.86 | 70.06 |
| Support Level | $3.21 | $11.47 |
| Resistance Level | $3.76 | $12.20 |
| Average True Range (ATR) | 0.18 | 0.08 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 85.99 | 93.42 |
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.
Nuveen Massachusetts Quality Municipal Income Fund is a diversified closed-end management investment company. The Fund's objective seeks to provide current income exempt from both regular federal and Massachusetts income taxes and to enhance portfolio value relative to the Massachusetts municipal bond market by investing in tax-exempt Massachusetts municipal obligations that are underrated or undervalued or that represent municipal market sectors that are undervalued.